Science Press Release Distribution Solutions
Amplify your scientific and biotech announcements with CorporatePRwire’s Science Press Release Distribution service. Whether you’re publishing groundbreaking research, launching new lab technology, announcing a CRO partnership, or sharing financial results from your scientific instrumentation business, our distribution network puts your story in front of journalists, investors, and industry stakeholders who matter. From immunofluorescence innovation to pharmaceutical R&D milestones, get your science news the visibility it deserves — submit your press release today.
High-Sensitivity Detection Breaks Technical Barriers! Cloud-Clone’s Small Molecule Hormone ELISA Kits Elevate Global Biomedical Research Standards News Lead
KATY, TX / 500NewsWire / July 13, 2026 / Hormones act as invisible signaling messengers regulating nearly all biological activities, playing irreplaceable roles in inflammation, reproductive development, tumor
Scientists Explore How Urban Night Air Chemistry Is Quietly Reshaping Plant Growth Patterns
Falls Church, VA / 500NewsWire / July 7, 2026 / As cities continue to expand, scientists are taking a closer look at an environmental change that has
Guide to Avoid Pitfalls in Primary Cell Procurement Released! Cloud-Clone Corp. Unveils Buying Guide for Novice Researchers to Boost Research Efficiency
Introduction Katy, TX / 500NewsWire / July 6, 2026 / In the fields of life sciences and pharmaceutical R&D, primary cells retain original genetic characteristics and highly
Fast, Accurate and Stable: Cloud-Clone Takes the Lead in the Immunofluorescence Technology Sector Through Core Competitive Strength
KATY, TX / 500NewsWire / July 1, 2026 / In the wave of precision medicine development and accelerated iteration of life science technology, immunofluorescence (IF) technology has become
Deeply Cultivating Brain Disease Sector, Cloud-Clone Wuhan Forges New Edges in CRO Services
KATY, TX / CorporatePRwire / June 22, 2026 / World Parkinson’s Day, observed on April 11 annually, continuously raises public awareness of the health and public health
Landmark Liver Fibrosis Research Published in Cell, Cloud-Clone Aids ROCK2-Targeted Drug TDI01 Development
Breakthrough Study in Cell Paves Way for ROCK2-Targeted Therapy TDI01 in Liver Fibrosis KATY, TX / CorporatePRwire / June 16, 2026 / In April 2026, a groundbreaking study—Selective